Multimed has been working with the Editors of Current Oncology to standardize our guidelines for authors and to simplify the peer review process. We w

CO-LOGO-JUNE

Multimed has been working with the Editors of Current Oncology to standardize our guidelines for authors and to simplify the peer review process. We would like to take the opportunity to let you know about some changes that will be implemented over the next month:

Simplified Journal Sections

In order to simply the online submission process for authors, and better display our articles in both print and online format we will be simplifying our journal sections. Authors will be asked to submit their article to one of the following categories; Original Article, Review Article, Case Report, Commentary, Guest Editorial, Letter to the Editor, Meeting Report, Perspectives in Oncology, Practice Guidelines, or Short Communication.
Updated Author Guidelines

We are currently in the process of updating our “Information to Authors” page. The purpose is to give information to authors about the journal, submission types and instructions, manuscript preparation, editorial policies, author fees, and manuscript submission all in a single location. Policies and preparation guidelines (including word count and format) will also be provided for each journal section.
Implementation of Review Form

Based on the feedback from our section editors, all journal reviewers will be asked to complete a standard review form within our online system. Reviewers will be asked to rate an article based on outlined criteria. This will simplify the review process for both reviewers and our editors, and help to ensure that we publish articles that are high priority and have the greatest impact within the Canadian Oncology Community.

We are confident these changes will be helpful to all of our contributors. As always, your feedback and comments are always welcome.

We would also like to take the opportunity to invite you to recommend information to include in our newsletter. We welcome information that is of importance to the Oncology community such as events, oncology conferences, important publications and clinical trials. Please send any recommendations to current_oncology@multi-med.com.

Multimed-clean

*Multimed Inc.*
Publisher of _Current Oncology_
***
CSL-468x60
***
InPress-CON

The latest issue of Current Oncology is now available online. Please visit the following link to view full text articles from Volume 19, Number 3 (June 2012):
http://www.current-oncology.com/index.php/oncology/issue/current/showToc

Highlights from the issue include:

The Euthanasia Debate – A Special Series
We invite you to join us in the debate! Click on the links below to view articles from this series.
* Pereira’s attack on legalizing euthanasia or assisted suicide: smoke and mirrors
* Casting stones and casting aspersions: let’s not lose sight of the main issues in the euthanasia debate
* Assisted death and the slippery slope—finding clarity amid advocacy, convergence, and complexity

“Cancer System Indicator Snapshots” – A new series in Current Oncology
This issue contains the first article titled “Recently published indicators allow for comparison of radiation treatment rates relative to evidence-based guidelines for rectal cancer” of the Cancer System Indicator Snapshots series. The series is an initiative of the Canadian Partnership Against Cancer (CPAC). Click here to view an introduction to the series written by Dr. Heather Bryant, Vice-President of Cancer Control for the CPAC.

***
LookingAhead-CON

Future Table of Contents

The future table of contents for Current Oncology, Volume 19, Number 4 (August 2012) is now available. For the most up-to-date listing of scheduled papers, please visit the following link:
http://www.current-oncology.com/index.php/oncology/about/futureTOC

Watch for the upcoming Supplement in June 2012!

Personalized Medicine in Metastatic NSCLC: A Canadian Perspective

Guest Editor, Dr. Vera Hirsh, has invited respected Canadian authorities in lung cancer to describe and discuss the topics related personalized medicine in metastatic NSCLC. This supplement will be published in both print & online. The goal of this supplement is to provide a complete review of present and future approaches to personalized medicine in advanced NSCLC in Canada.

***
ReadersChoice-COn

Have you had the chance to view these Current Oncology “Most-Read” articles?

Most Read Articles in PubMed Central (May 2012)

A primer of bone metastases management in breast cancer patients
Petrut B, Trinkaus M, Simmons C, Clemons M
Curr Oncol. 2008 Jan;15(Suppl 1):S50-7

Management of skin rash during EGFR-targeted monoclonal antibody treatment for gastrointestinal malignancies: Canadian recommendations
Melosky B, Burkes R, Rayson D, Alcindor T, Shear N, Lacouture M
Curr Oncol. 2009 Jan;16(1):16-26

Prevention and management of chemotherapy-induced diarrhea in patients with colorectal cancer: a consensus statement by the Canadian Working Group on Chemotherapy-Induced Diarrhea
J.A. Maroun, L.B. Anthony, N. Blais, R. Burkes, S.D. Dowden, G. Dranitsaris, B. Samson, A. Shah, M.P. Thirlwell, M.D. Vincent, R. Wong
Curr Oncol. 2007 Feb; 14(1):13-20

Most Read Recently* Published Articles at www.current-oncology.com

A comprehensive bone-health management approach for men with prostate cancer receiving androgen deprivation therapy
Lee CE, Leslie WD, Czaykowski P, Gingerich J, Geirnaert M, Lau YK
Curr Oncol. 2011 Aug;18(4):e163-72

Canadian recommendations for the treatment of recurrent or progressive glioblastoma multiforme
Easaw JC, Mason WP, Perry J, Laperrière N, Eisenstat DD, Del Maestro R, Bélanger K, Fulton D, Macdonald D; for the Canadian Glioblastoma Recommendations Committee
Curr Oncol. 2011 Jun;18(3):e126-e136

Emerging trends in the treatment of triple-negative breast cancer in Canada: a survey
Verma S, Provencher L, Dent R.
Curr Oncol. 2011 Aug;18(4):180-90

*Published within past 12 months

***
HaveYouHeard-CON

Clinical Series Live: Personalized Treatment in Breast Cancer: Improving Outcomes in Advanced Disease

Clinical Series Live: Personalized Treatment in Breast Cancer: Improving Outcomes in Advanced Disease is sponsored by the Massachusetts Medical Society and chaired by Karen Antman, MD, Dean of the Boston University School of Medicine. This live complimentary virtual CME summit brings together leading experts in breast cancer research—live & online—to discuss the latest topics and new developments in breast cancer. Watch Eric Winer, MD, of the Dana Farber Cancer Center present his perspectives on optimizing treatment for patients with triple negative disease and compare your decision-making in managing patients with locally advanced and metastatic cancers to that of faculty member William Gradishar, MD, of the Northwestern Feinberg School of Medicine. All sessions are presented online via live streaming video and offer real-time Q&A chats with faculty.

Join us on Monday, June 18th from 11AM – 3PM ET. Register now at www.clinicalserieslive.com. There’s no cost to participate.

Gain a Unique Global Perspective on Cancer Control

The UICC 2012 World Cancer Congress (WCC2012) represents a unique and ideal platform for the international cancer control community to connect, discuss, share, and learn in order to find solutions to reduce the impact of cancer globally.

From plenary to track sessions, the WCC2012 has world-class speakers lined-up, such as:
Dr. Elizabeth Blackburn, Dr. Graham A. Colditz, Dr. John Seffrin, Dr. Elizabeth Eisenhauer, Dr. Haik Nikogosian, HRH Princess Dina Mired, Prof. Richard Sullivan, Sir George Alleyne.

Over 3,000 clinicians, researchers, epidemiologists, health professionals, tobacco control professionals, nurses, policy makers, patient advocates, to programme managers will gather to address:

1. Prevention and early detection (including tobacco control)
2. Cancer care and survivorship
3. Palliation and pain control
4. Systems in cancer control

Register before July 31 to benefit from a discounted rate - http://bit.ly/WCCRegister

Current Oncology Welcomes New Members to our Editorial Team

We are pleased to welcome our newest section editors to our editorial team:
* Dr. Lesley Seymour, NCIC Clinical Trials Group, Kingston, ON (Section Editor, Clinical Trials)
* Dr. Dugald Seely, Ottawa Integrative Cancer Centre, Ottawa, ON (Section Editor, Integrative Oncology)
* Mary Shariff, University of Manitoba, Winnipeg, MB (Section Editor, Medical Legal)
* Dr. Elisabeth Isenring, University of Queensland, Australia (Section Editor, Nutrition)
* Dr. Rona Cheifetz, BC Cancer Agency and Vancouver General Hospital ,Vancouver, BC (Section Editor, Surgical Oncology)
* Dr. Martin Gleave, Vancouver Prostate Centre, Vancouver, BC (Section Editor, Translational Research)

Current Oncology Publishes Professional Supplements

Current Oncology has been involved in providing in-depth professional supplements since its inception. Over the years, Current Oncology has published a variety of supplements covering a range of topics dedicated to providing valuable up-to-date educational material to the Canadian oncology community. Professional supplements are an ideal way for organizations, associations and industry to publish conference abstracts and proceedings, results of meetings or seminars, review articles on a dedicated subject, and consensus guidelines and statements. For more information please contact Heather Shand.

Current Oncology Partners with Meetings

As Canada’s premier Oncology journal, we are pleased to partner with meetings and conferences across Canada to promote the meeting to our readership.

Current Oncology has recently partnered with the 8th Annual Advanced Learning in Palliative Medicine Conference. Additional copies of our June 2012 issue were distributed to delegates of the conference, which was held June 7th-9th, 2012 in Kingston, Ontario.

Copies of our June and August 2012 issue will also be available to delegates of the World Cancer Congress, which is being held August 27-30th in Montreal.

If you are interested in partnering with Current Oncology or distributing copies of the journal to delegates at your meeting, please contact Laura Hope.

***
QuickLinks-CON
***
CO-Newsletter---Banner---SubManuscriptr

Contact Us

Address-CON
 
Email-CON
 
Phone-CON
 
Web-CON
email facebook twitter
1px